REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., trading under the ticker PAIC, filed a 10-Q quarterly report with the U.S. Securities and Exchange Commission on June 22, 2021, bearing accession number 0001213900-21-033574. The company operates in the life sciences and biotechnology sector, reflecting the sustained SPAC interest in healthcare and bioscience targets that characterized the 2020–2021 blank-check boom. The 10-Q filing represents a routine periodic disclosure, capturing the company's financial position and operational developments for the relevant quarter. Investors and analysts tracking SPAC-related biotech entities can find comprehensive filing histories, status updates, and deal timelines for PAIC and hundreds of comparable vehicles on SpacDesk — sign up today for full data access.